Atomera Incorporated filed its quarterly report on Form 10-Q with the SEC on October 30, 2026, covering the three and nine months ended September 30, 2026, disclosing a net loss of $6,006 thousand for the third quarter and total cash and cash equivalents of $23,268 thousand at quarter-end.

Key Highlights

  • Q3 2026 net loss: $6,006 thousand, compared to $5,573 thousand in Q3 2025, according to the filing.
  • Nine-month net loss: $18,415 thousand for the nine months ended September 30, 2026, versus $15,749 thousand for the same period in 2025.
  • Cash and cash equivalents: $23,268 thousand as of September 30, 2026, up from $19,210 thousand at December 31, 2025.
  • Short-term investments: $11,560 thousand as of September 30, 2026, compared to zero at December 31, 2025.
  • Registered direct offering: The company raised net proceeds of $23,596 thousand through a registered direct offering of 5,000 thousand shares of common stock during Q1 2026.
  • Shares outstanding: 39,083,404 shares of common stock outstanding as of October 27, 2026, up from 32,354 thousand at December 31, 2025.
  • Accumulated deficit: $260,109 thousand as of September 30, 2026, versus $241,694 thousand at December 31, 2025.

Atomera's Q3 2026 Financial Results: Losses Widen as Operating Costs Rise

According to the filing, Atomera Incorporated (NASDAQ:ATOM) reported zero revenue for the three months ended September 30, 2026, compared to $11 thousand in Q3 2025. For the nine-month period, revenue was $169 thousand versus $15 thousand in the prior-year period. Total operating expenses for Q3 2026 were $6,328 thousand, up from $5,676 thousand in Q3 2025, driven by increases in research and development ($3,647 thousand versus $3,304 thousand), general and administrative expenses ($2,338 thousand versus $2,165 thousand), and selling and marketing costs ($343 thousand versus $207 thousand).

The loss from operations for the third quarter was $6,328 thousand, compared to $5,793 thousand in the same quarter of 2025, the filing disclosed. Other income, net, partially offset the operating loss at $322 thousand for Q3 2026, including interest income of $254 thousand and accretion income of $75 thousand. Basic and diluted net loss per common share for Q3 2026 was $(0.15), compared to $(0.17) in Q3 2025, with weighted average shares outstanding increasing to 38,899 thousand from 31,128 thousand.

The company's balance sheet showed total assets of $38,439 thousand as of September 30, 2026, up from $21,093 thousand at December 31, 2025, the filing reported. The increase in assets was accompanied by growth in total stockholders' equity to $32,794 thousand from $18,381 thousand over the same period, reflecting capital raised through the registered direct offering and at-the-market stock sales. Total liabilities rose to $5,645 thousand from $2,712 thousand, with current operating lease liability increasing to $1,908 thousand from $147 thousand, and the operating lease right-of-use asset rising to $2,731 thousand from $884 thousand, according to the filing.

What Was Disclosed

Atomera filed its Form 10-Q for the quarter ended September 30, 2026, reporting a Q3 net loss of $6,006 thousand, nine-month net loss of $18,415 thousand, cash of $23,268 thousand, and 39,083,404 shares outstanding, with capital raised via a registered direct offering of 5,000 thousand shares during the period.